53 research outputs found
Low circulating dendritic cell count after allogeneic stem cell transplantation (SCT) predicts death, relapse, and acute graft-versus-host disease (AGVHD)
Second Solid Cancers After Allogeneic Hematopoietic-Cell Transplantation Using Busulfan-Cyclophosphamide Conditioning
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), disproportionately affects immunocompromised and elderly patients. Not only are hematopoietic cell transplantation (HCT) and chimeric antigen receptor (CAR) T-cell recipients at greater risk for severe COVID-19 and COVID-19–related complications, but they also may experience suboptimal immune responses to currently available COVID-19 vaccines. Optimizing the use, timing, and number of doses of the COVID-19 vaccines in these patients may provide better protection against SARS-CoV-2 infection and better outcomes after infection. To this end, current guidelines for COVID-19 vaccination in HCT and CAR T-cell recipients from the American Society of Transplantation and Cellular Therapy Transplant Infectious Disease Special Interest Group and the American Society of Hematology are provided in a frequently asked questions format
Eficácia in vitro de desinfetantes utilizados na anti-sepsia dos tetos frente a leveduras isoladas do leite de vaca com mastite
“Mini” methotrexate and FK506 as gvhd prophylaxis in pediatric umbilical cord blood transplantation
238Oral (PO) Valganciclovir (VGC) for preemptive therapy of Cytomegalovirus (CMV) Antigenemia (AG) in hematopoietic stem cell transplant (HSCT) recipients
Post marketing surveillance of voriconazole (VORI) use in hematopoietic stem cell transplant (HSCT) recipients at a single academic institution
Tacrolimus and “Mini” Methotrexate is an Effective Regimen for Prevention of Graft-Versus-Host-Disease In Children Undergoing Umbilical Cord Blood Transplant
- …